Literature DB >> 2837357

Human parvovirus B19 and pregnancy.

L J Anderson1, E S Hurwitz.   

Abstract

Although B19 infection during pregnancy usually has no adverse effect on the fetus, it can cause fetal death. Recent studies make it possible to estimate risk of infection following different types of exposure and the risk of fetal death after infection. The most common clinical manifestations of B19 infection are erythema infectiosum and aplastic crisis in patients with chronic hemolytic anemias.

Entities:  

Mesh:

Year:  1988        PMID: 2837357

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  14 in total

1.  Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.

Authors:  S J Rosenfeld; K Yoshimoto; S Kajigaya; S Anderson; N S Young; A Field; P Warrener; G Bansal; M S Collett
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

Review 2.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

3.  Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions.

Authors:  T Saikawa; S Anderson; M Momoeda; S Kajigaya; N S Young
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

Review 4.  Environmental teratogens.

Authors:  R L Brent; D A Beckman
Journal:  Bull N Y Acad Med       Date:  1990 Mar-Apr

Review 5.  Intrauterine transfusion with red cells and platelets.

Authors:  K J Moise
Journal:  West J Med       Date:  1993-09

6.  Detection of parvovirus B19 in macerated fetal tissue using in situ hybridisation.

Authors:  C Walters; D G Powe; C J Padfield; D G Fagan
Journal:  J Clin Pathol       Date:  1997-09       Impact factor: 3.411

7.  Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions.

Authors:  S Kajigaya; H Fujii; A Field; S Anderson; S Rosenfeld; L J Anderson; T Shimada; N S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

8.  Quantitative competitive-PCR assay to measure human parvovirus B19-DNA load in serum samples.

Authors:  Massimiliano Bergallo; Chiara Merlino; Roberta Daniele; Cristina Costa; Alessandro Negro Ponzi; Rossana Cavallo
Journal:  Mol Biotechnol       Date:  2006-01       Impact factor: 2.695

9.  Parvovirus B19 outbreak on an adult ward.

Authors:  C Seng; P Watkins; D Morse; S P Barrett; M Zambon; N Andrews; M Atkins; S Hall; Y K Lau; B J Cohen
Journal:  Epidemiol Infect       Date:  1994-10       Impact factor: 2.451

10.  Localization of an immunodominant domain on baculovirus-produced parvovirus B19 capsids: correlation to a major surface region on the native virus particle.

Authors:  C S Brown; T Jensen; R H Meloen; W Puijk; K Sugamura; H Sato; W J Spaan
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.